Technological advancements in last couple of decades have made
diagnosis of lung cancer easy using endobronchial ultrasound (EBUS)
biopsy technique. Endobronchial ultrasound is minimally invasive
technique that uses ultrasound along with bronchoscope to examine
airway walls and structure adjacent to it. Ultrasound technology used
in this procedure allows examination of multilayer tracheobronchial
wall structure better than any other imaging technique. Endobronchial
ultrasound biopsy has become best alternative to other traditional
procedures such as fluoroscopic guided biopsy, fiberoptic
bronchoscope, mediastinoscopy or thoracotomy. Using these traditional
limits the view of bronchoscopist to bronchial mucosa and lumen,
whereas EBUS has widen the vision beyond tracheobronchial wall.
Report Overview @
https://www.transparencymarketresearch.com/endobronchial-ultrasound-biopsy-market.html
Endobronchial ultrasound biopsy is performed on outpatient basis
under local anesthesia using thin needle aspiration. Endobronchial
ultrasound guided tracheobronchial needle aspiration method has
enabled real-time aspiration of lesions near to trachea and large
bronchi. The use of this technique is rapidly gaining popularity due
to accumulation of large amount of data related to safety and
effectiveness of the technique. As per European Respiratory Journal,
EBUS presents positive likelihood ratio of 26.8 and negative
likelihood ratio of 0.28. According to American College of Chest
Physicians, EBUS is recommended as first procedure to before surgical
staging for lung cancer diagnosis in the U.S.
The global market endobronchial ultrasound biopsy is expected to be
driven by incidence of lung cancer all over the world. According to
Cancer Research U.K., 46,403 new lung cancer cases were diagnosed in
U.K. in 2014, which accounted for 13% of all new cancer cases.
According to American Lung Association, Lung cancer is the most
common cancer across the globe accounting for 1.8 Mn new cases
worldwide in 2012. And is most prevalent in elderly person. 83% of
patients living with lung cancer are 60 years-old or above. Growing
geriatric population thus can be a factor contributing to growth of
endobronchial ultrasound biopsy market over the forecast period.
However, the biggest restraint for growth of endobronchial ultrasound
biopsy market is unawareness about the technique. Despite the
technique is being used for last two decade in matured markets,
developing countries such as India and China have recently introduced
to this technique.
Download Report Brochure @
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=25982
One of the main applications of endobronchial ultrasound biopsy is in
staging of cancer. Introduction of this technique has made dramatic
changes in treatment planning for lung cancer. In 2016, American
Medical Association created three new CPT codes for endobronchial
ultrasound biopsy procedure. Thus all the services using EBUS
including aspiration biopsy are reimbursed by Medicare
Hospitals end user segment is expected to be dominant in global
endobronchial ultrasound biopsy market due to high patient population
EBUS procedure is generally provided on outpatient or day case
basis.
Regionally, global endobronchial ultrasound biopsy market is
segmented into five key regions viz. North America, Latin America,
Europe, Asia Pacific, and Middle East & Africa. North America
clearly dominates the global market endobronchial ultrasound biopsy
due to high prevalence and growing adoption of technique by
physicians and patients. Europe is expected to be the second largest
market endobronchial ultrasound biopsy. Asia pacific endobronchial
ultrasound biopsy market is expected to witness steady growth over
the forecast period of 2017–2025, primarily due to delayed
introduction of EBUS technique in the region and limited availability
of qualified resources to perform the procedure.
Pre-Book Full Report @
https://www.transparencymarketresearch.com/checkout.php?rep_id=25982<ype=S
Olympus Europa SE & CO. KG is the major player that provides
endobronchial ultrasound biopsy systems globally. Some of the popular
brands of video bronchoscopes provided by the company include
BF-Q180, BF-P180, BF-3C160, etc.
About Us
Transparency Market Research (TMR) is a market intelligence company,
providing global business information reports and services. Our
exclusive blend of quantitative forecasting and trends analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants,
use proprietary data sources and various tools and techniques to
gather, and analyze information. Our business offerings represent the
latest and the most reliable information indispensable for businesses
to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such
as pharmaceuticals, chemicals, energy, food & beverages,
semiconductors, med-devices, consumer goods and technology. These
reports provide in-depth analysis and deep segmentation to possible
micro levels. With wider scope and stratified research methodology,
TMR’s syndicated reports strive to provide clients to serve their
overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
https://www.transparencymarketresearch.com
No comments:
Post a Comment